Miraterra, a British Columbia-based technology company known for unlocking measurement and insight across soil, plants, and food through breakthroughs in Raman spectroscopy, has acquired the assets of Bay Area-founded Ag-tech company, Trace Genomics Inc., including the full suite of Intellectual Property (IP), in-market products, and an analytical lab in Ames, Iowa.
This strategic acquisition combines forces of two leading technology platforms to rapidly advance the field of soil-to-table measurement and insights — supporting agriculture and advancing the resilience and restoration of our global soil health.
"Miraterra's integration of Trace's technology, lab, and team accelerates our ability to deliver breakthrough soil-to-table measurement at scale. We're making advanced testing more accessible, useful, and trusted across the agricultural value chain. We invite customers to explore Trace's proven products and our expanding offerings, and we welcome researchers and institutions to partner with us in unlocking new insights from decades of rich soil biology and soil chemistry data," says Nate Kelly, CEO of Miraterra.
Recognizing that soil hosts 59% of life on Earth, Trace pioneered a new era of soil testing by harnessing DNA sequencing to reveal the hidden biology and microbiome beneath our feet. This created excitement within the agriculture industry as Trace's platform allowed growers and agronomists to see their fields in an entirely new way, improving crop yield and soil health through tailored recommendations.
Click here to see more...